Monoclonal antibodies to activated CDK4: Use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27

Coulonval, K., Vercruysse, V., Paternot, S., Pita, J.M., Corman, R., Raspé, E., Roger, P.P. Cell Cycle, 21(1) :12-32 (jan. 2022)

Previous
Previous

An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4

Next
Next

Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of malignant pleural mesotheliomas to CDK4/6 inhibition